Adamas Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Adamas Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Adamas Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Adamas Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Adamas Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20220062204A1 | Application | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SEIZURE-RELATED DISORDERS | A61K31/165; A61K31/19; A61K31/192; A61K31/4015; A61K9/0053; A61K9/16; A61K9/1635; A61K9/5026; A61K9/5042; A61K9/5047; A61K9/5078; A61P25/08 | March 03, 2022 |
| US20220054497A1 | Application | PREVENTION OF ATHEROSCLEROTIC EVENTS WITH DIRECT FACTOR Xa INHIBITORS | A61K31/4365; A61K31/437; A61K31/44; A61K31/4425; A61K31/4427; A61K31/444; A61K31/4545; A61K31/5377; A61K9/20 | February 24, 2022 |
| HUE055779T2 | Application | AMANTADINE FOR IMPROVING GAIT IN MULTIPLE SCLEROSIS | A61K9/5026; A61K9/5047; A61P21/00; A61K9/0053; A61K9/5078; A61K9/48; A61K31/13; A61K45/06 | December 28, 2021 |
| SI3215132T1 | Grant | AMANTADINE FOR IMPROVING GAIT IN MULTIPLE SCLEROSIS | A61K31/13; A61K45/06; A61K9/0053; A61K9/48; A61K9/5026; A61K9/5047; A61K9/5078; A61P21/00 | November 30, 2021 |
| EP3909569A1 | Application | VERFAHREN ZUR VERABREICHUNG VON AMANTADIN-ZUSAMMENSETZUNGEN | A61K31/13; A61K45/06; A61K9/0053; A61K9/48; A61K9/5026; A61K9/5047; A61K9/5078; A61P21/00 | November 17, 2021 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer